Inventor
Pratik Devasthale
Inventor
Plainsboro, NJ, US
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds37%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes22%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium12%
C07CAcyclic or carbocyclic compounds3%
PatentTitleYear
11,014,922Cyclobutane- and azetidine-containing mono and spirocyclic compounds as aV integrin inhibitors202110,966,967Aryl dihydropyridinones and piperidinone MGAT2 inhibitors202110,968,2193-substituted propionic acids as aV integrin inhibitors202110,851,098Azole amides and amines as alpha v integrin inhibitors202010,695,328Aryl dihydropyridinones and piperidinone MGAT2 inhibitors202010,369,140Aryl dihydropyridinones and piperidinone MGAT2 inhibitors20199,974,778Substituted pyridinones as MGAT2 inhibitors20189,901,572'Aryl dihydropyridinones and piperidinone MGAT2 inhibitors'20189,663,466'Aryl dihydropyridinones and piperidinone MGAT2 inhibitors'20179,187,424'Aryl dihydropyridinones and piperidinone MGAT2 inhibitors'20158,791,091'Aryl dihydropyridinone and piperidinone MGAT2 inhibitors'20148,754,211'Azolotriazinone melanin concentrating hormone receptor-1 antagonists'20148,580,959'Azolotriazinone melanin concentrating hormone receptor-1 antagonists'20138,415,386'Azolopyrrolone melanin concentrating hormone receptor-1 antagonists'20138,263,659'Thyroid receptor ligands'20127,989,433'Substituted thieno[3,2-D]pyrimidines as melanin concentrating hormone receptor-1 antagonists'20117,951,793'Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method'20117,579,479'Substituted acid derivatives useful as antidiabetic and antiobesity agents and method'20097,557,143'Thyroid receptor ligands'20097,521,557'Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods'20097,279,485'Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method'20077,241,780'Substituted acid derivatives useful as antidiabetic and antiobesity agents and method'20077,084,162'Substituted acid derivatives useful as antidiabetic and antiobesity agents and method'20067,053,106'Substituted acid derivatives useful as antidiabetic and antiobesity agents and method'20066,919,358'Substituted acid derivatives useful as antidiabetic and antiobesity agents and method'20056,727,271'Substituted acid derivatives useful as antidiabetic and antiobesity agents and method'20046,673,815'Substituted acid derivatives useful as antidiabetic and antiobesity agents and method'20046,653,314'Substituted acid derivatives useful as antidiabetic and antiobesity agents and method'20036,414,002'Substituted acid derivatives useful as antidiabetic and antiobesity agents and method'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002–2021Patents assigned to BRISTOL MYERS SQUIBB CO (27)· patent assignee history
2002–2021Based in Plainsboro, NJ, US· patent location history
2005Patents assigned to BRISTOL MEYERS SQUIBB CO (1)· patent assignee history
2012–2013Patents assigned to DEVASTHALE PRATIK (3)· patent assignee history
2013Patents assigned to WASHBURN WILLIAM N (2)· patent assignee history
2013Patents assigned to AHMAD SALEEM (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 27 | 2002–2021 |
| DEVASTHALE PRATIKself | 3 | 2012–2013 |
| WASHBURN WILLIAM N | 2 | 2013 |
| AHMAD SALEEM | 1 | 2013 |
| BRISTOL MEYERS SQUIBB CO | 1 | 2005 |
Locations
| Location | Patents | Span |
|---|---|---|
| Plainsboro, New Jersey, US | 29 | 2002–2021 |